Castle Biosciences, Inc. (CSTL)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 24.41 |
| Open | 24.28 |
| Bid | 23.72 x 400 |
| Ask | 23.82 x 100 |
| Day's range | 23.70 - 24.56 |
| 52-week range | 9.26 - 26.70 |
| Volume | |
| Avg. volume | 249,206 |
| Market cap | 656.913M |
| Beta (5Y monthly) | 0.92 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
DecisionDx®-SCC Significantly Improves Prediction Accuracy of Metastatic Events after Mohs Surgery in New Study of Patients with High-Risk Cutaneous Squamous Cell Carcinoma Tumors of the Head and Neck
FRIENDSWOOD, Texas, May 03, 2024--Castle Biosciences will share new data supporting the utility of its DecisionDx®-SCC test at the ACMS Annual Meeting in Phoenix.
- Business Wire
Castle Biosciences Reports First Quarter 2024 Results
FRIENDSWOOD, Texas, May 02, 2024--Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced its financial results for the first quarter ended March 31, 2024.
- Business Wire
Castle Biosciences Kicks off Skin Cancer Awareness Month with a Ribbon Cutting to Celebrate the City of Friendswood’s Designation as a Sun Safe Leadership Model City by IMPACT Melanoma
FRIENDSWOOD, Texas, April 30, 2024--Castle Biosciences announced its support of key skin cancer advocacy events and initiatives throughout May in honor of Skin Cancer Awareness Month.
© 2024 Yahoo. All rights reserved.